Articles about Cyrus Biotech

Cyrus Biotech spins out company to expand reach of versatile drug development software

Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software technology, with the… Read More

Cyrus Biotechnology and CRISPR pioneers team up to boost gene-editing therapies

Seattle-based Cyrus Biotechnology says it’ll collaborate with the Broad Institute of MIT and Harvard on ways to optimize CRISPR gene-editing… Read More

Tech Moves: Big ins and outs at Amazon; Gates Foundation hires CFO; Techstars vet joins Pioneer Square Labs; and more

There’s a lot of movement in Amazon’s vast world of entertainment, gaming and audio programming, with industry veterans coming in… Read More

Tech Moves: MicroVision appoints new CEO; Convoy adds longtime Tableau exec; and more

MicroVision, the Redmond, Wash.,-based maker of laser projection technology, is under new leadership. The company announced that longtime technology executive… Read More

Cyrus Biotech raises $8M to boost protein modeling toolkit for drug discovery

Cyrus Biotechnology is getting an $8 million infusion for its cloud-based protein modeling and design toolkit, thanks to a Series… Read More

Designer proteins, created and edited on computers, open up new biotech frontiers

Synthetic genomes and gene editing are big things today, but the next big things in biotechnology could be proteins that are… Read More

University of Washington licenses Rosetta protein software to Cyrus Biotech

CoMotion at the University of Washington is licensing the Rosetta protein design software to Cyrus Biotechnology, which plans to create a more user-friendly… Read More